Versuchen GOLD - Frei
Does US cancer drug nod make Cipla attractive?
Mint Bangalore
|April 18, 2025
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
Diese Geschichte stammt aus der April 18, 2025-Ausgabe von Mint Bangalore.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Bangalore
Mint Bangalore
Vedanta’s bond plan faces query on $600 mn loan funds
$250 mn of $500mn loan still not drawn: Vedanta
1 mins
September 30, 2025
Mint Bangalore
WeWork India preps ₹3,000 cr IPO in share sale by promoters
WeWork India Management Ltd, the country’s largest flexible workspace operator, will launch its initial public offering (IPO) on Friday as its shareholders plan to raise up t0 ₹3,000 crore.
1 mins
September 30, 2025
Mint Bangalore
Top exec’s exit puts focus on TCS Al woes
itself was overhauled at least three times in the past three years. The Mumbai-based firm isalso laying off 12,200 mid-to senior-level executives, or 2% of its workforce, to become “future ready”.
2 mins
September 30, 2025
Mint Bangalore
Dubai halts HDFC from adding new customers
HDFC Bank Ltd, the largest private sector lender, has been banned from onboarding new customers at its Dubai branch after a regulator flagged lapses in its processes. The bank was penalized by a Dubai regulator for offering financial services to local clients who were not onboarded at the Dubai International Financial Centre, the Mumbai-based lender said in an exchange filing late on Friday.
1 min
September 30, 2025
Mint Bangalore
Enviable dilemma
It's a dilemma that the Reserve Bank of India (RBI) wouldn't mind being caught in.
1 min
September 30, 2025
Mint Bangalore
Walmart CEO issues wake-up call: ‘AI Is going to change literally every job’
Walmart executives aren’tsugarcoating the message: Artificial intelligence will wipe out some jobs and reshape its workforce.
4 mins
September 30, 2025
Mint Bangalore
Personal shoppers lift India’s premium fashion retail sales
Stylists help customers mix and match outfits, boosting confidence and setting brands apart
2 mins
September 30, 2025

Mint Bangalore
Russia's exports to India falter, UAE rises as formidable competitor
India’s imports from Russia declined 5.54% to $26.46 billion in the first five months of the current financial year, bringing the country’s secondlargest supplier of goods close to being overtaken by third-placed United Arab Emirates (UAE), government data showed.
1 mins
September 30, 2025

Mint Bangalore
RACING AHEAD: ARE AUTO STOCKS STILL A BUY?
India's auto sector is displaying all the signs of a classic bull market. But there are risks
8 mins
September 30, 2025
Mint Bangalore
Govt warns Kerala on amoeba case surge
The central government has asked Kerala authorities to step up monitoring after the state reported a surge in cases of a rare brain-eating amoeba. Kerala health minister Veena George has said the state has recorded 80 cases and 21 deaths so far in 2025.
1 min
September 30, 2025
Listen
Translate
Change font size